What Are EGFR Exon20 Insertions? 


EGFR Exon20 insertions are an epidermal growth factor (EGFR) mutation that occurs in about 2% of people with non-small cell lung cancer, or NSCLC.

What is NSCLC?

There are 2 main types of lung cancer:


Most people with lung cancer (about 8 in 10) have NSCLC, the same type as you

This is a rare mutation, but you're not alone.

Identifying your particular gene mutation can help you and your doctor choose specific treatment options—or targeted therapies—that are more likely to effectively treat your disease.

Treating EGFR Exon20 insertion mutations

The treatment of EGFR Exon20 insertion mutations is advancing and more treatment options are now available. This is a time of hope.

EXKIVITY® (mobocertinib) is helping to change the treatment story for people like you.